CLINICAL_TRIALS
trial_result
· 2022-07-29
Clinical Trial Update: Efficacy and Safety of Orally Administered DS102 in Patients With Acute Alcoholic Hepatitis [Phase 2]
Summary
Phase 2 trial of DS102 for severe acute decompensated alcoholic hepatitis was terminated; results posted but no further development in this phase.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Afimmune | Conditions: Severe Acute Decompensated Alcoholic Hepatitis | Phase 2 | Status: TERMINATED | Results posted: 2022-07-29